Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03173560
Title Trial to Assess Safety and Efficacy of Lenvatinib in Combination With Everolimus in Participants With Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eisai Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU | POL | NLD | ITA | GRC | GBR | FIN | ESP | CZE | CAN | AUS


No variant requirements are available.